In this week's Homerun Slides, the cardiovascular risk of using sulfonylureas.

The first large-scale studies of the prediction of T1DM relied upon the detection of cytoplasmic islet cell autoantibodies (ICA) assays based on indirect immunofluorescence. High titer cytoplasmic ICA is most often associated with the presence of multiple islet autoantibodies and therefore a high risk of progression to diabetes.

Two pills provided greater glucose-lowering efficacy than three with low hypoglycemia risk.

Which format would you like to see for interviews? Video, audio (podcast), written transcript? Follow the link to respond!

Old tradition potentially benefits body’s organs, providing possible cure and treatment.

Healthier lifestyle found to be result of symptom treatment.

Diabetic nephropathy risk found on rise in 12- to 18-year-old patients.

Heart failure patients may not need sodium restrictions.

Metformin, sulfonylureas, and insulin studied in type 2 patients.

In part four of this interview with Dr. Mark Mattson, DIC publisher Steve Freed asks why have we not seen more studies on intermittent fasting to prevent diseases?